OPsumit USers Registry

  • STATUS
    Not Recruiting
  • participants needed
    5000
  • sponsor
    Actelion
Updated on 24 June 2021
Investigator
The Medical Research Network, LLC
Primary Contact
investigator Site (2.5 mi away) Contact
+128 other location
macitentan

Summary

Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.

Details
Condition Pulmonary Arterial Hypertension
Treatment Opsumit (macitentan)
Clinical Study IdentifierNCT02126943
SponsorActelion
Last Modified on24 June 2021

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note